KIT and cancer: We contend that perhaps the majority of risk factors converge to favor a limited number of cancer driving epigenetic states that in some cases further progress due to somatic genetic mutations including those of KIT and KRAS. Many decades of focus on somatic genomic alterations in TGCTs including awareness of near universal increase in copies of chromosome 12p have failed to uncover exceptional cancer driver genes.